The contribution of CI to the strategic decision making process: Empirical study of the European pharmaceutical industry.

De Montfort University Open Research Archive

Show simple item record

dc.contributor.author Badr, Ahmad
dc.contributor.author Madden, Emma
dc.contributor.author Wright, Sheila
dc.date.accessioned 2009-11-11T09:51:20Z
dc.date.available 2009-11-11T09:51:20Z
dc.date.issued 2006
dc.identifier.citation Badr, A., Madden, E. and Wright, S. (2006) The contribution of CI to the strategic decision making process: Empirical study of the European pharmaceutical industry. Journal of Competitive Intelligence & Management, 3 (4), pp.15-35 en
dc.identifier.issn 1937-1063
dc.identifier.uri http://hdl.handle.net/2086/2829
dc.description.abstract The practice of Competitive Intelligence (CI) is common in the US pharmaceutical industry but there is little evidence to suggest that the European industry has adopted CI to the same extent. This study reports on a specific sub-set of the overall CI activity, namely the contribution which CI makes to the strategic decision making (SDM) process. CI managers in the European pharmaceutical industry were selected and the results from 79 questionnaires and 14 in-depth interviews are provided. Results indicate that the CI activities in respondent firms are reasonably well established and also that the pharmaceutical industry appears to appreciate both the benefits, and requirements of a modern day CI function. However, the industry is not taking full advantage of the CI effort at every stage of the SDM process. Conclusions are drawn which highlight areas for potential improvement. The article also identifies the managerial implications from the findings with suggestions for further research topics associated with this area.
dc.language.iso en en
dc.publisher Society of Competitive Intelligence Professionals. en
dc.subject competitive intelligence
dc.subject competitive analysis
dc.subject decision making
dc.subject empirical study
dc.subject pharmaceutical industry
dc.subject Europe
dc.title The contribution of CI to the strategic decision making process: Empirical study of the European pharmaceutical industry. en
dc.type Article en
dc.identifier.doi http://www.scip.org/Publications/JCIMArticleDetail.cfm?ItemNumber=2539
dc.researchgroup Competitive Intelligence-Management Interface Teaching and Research Initiative (CIMITRI)
dc.peerreviewed Yes


Files in this item

This item appears in the following Collection(s)

Show simple item record